Integrated Advisors Network LLC Charles River Laboratories International, Inc. Transaction History

Integrated Advisors Network LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$204.13 - $302.4 $42,663 - $63,201	-209 Reduced 12.29%	1,491 $319,000
Q1 2022 May 02, 2022	SELL	$255.51 - $362.11 $29,128 - $41,280	-114 Reduced 6.28%	1,700 $483,000
Q4 2021 Feb 14, 2022	SELL	$351.38 - $448.68 $53,761 - $68,648	-153 Reduced 7.78%	1,814 $683,000
Q3 2021 Nov 15, 2021	BUY	$372.64 - $458.3 $12,669 - $15,582	34 Added 1.76%	1,967 $812,000
Q1 2021 May 17, 2021	BUY	$249.67 - $299.48 $28,961 - $34,739	116 Added 6.38%	1,933 $560,000
Q4 2020 Feb 12, 2021	BUY	$222.0 - $252.62 $29,082 - $33,093	131 Added 7.77%	1,817 $454,000
Q3 2020 Nov 09, 2020	BUY	$175.56 - $226.45 $21,242 - $27,400	121 Added 7.73%	1,686 $382,000
Q2 2020 Aug 13, 2020	BUY	$118.84 - $189.72 $185,984 - $296,911	1,565 New	1,565 $273,000

691

51.6M

259K

463K

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $8.38B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

Get notified when there are updates to the investment portfolio of Integrated Advisors Network LLC, based on Form 13F filings with the SEC.

Stay updated on Integrated Advisors Network LLC with notifications on news.